Javelin Pharms Inc patents expiration

1. Dyloject patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946292 JAVELIN PHARMS INC Formulations of low dose diclofenac and beta-cyclodextrin
Mar, 2027

(3 years from now)

Drugs and Companies using DICLOFENAC SODIUM ingredient

Market Authorisation Date: 23 December, 2014

Treatment: Management of pain


How can I launch a generic of DYLOJECT before it's drug patent expiration?
More Information on Dosage

DYLOJECT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic